Furthermore, to the best of our knowledge, this study demonstrates, for the first time, that inhibition of Notch3 signaling can specifically improve outcome from HIV-related CKD, uncovering a potential new target to prevent CKD progression in people with HIV-1. Here, NOTCH3 is linked to chronic kidney disease.